Cleared Traditional

K993633 - SYNTHETIC VDRL ANTIGEN

K993633 is an FDA 510(k) clearance for SYNTHETIC VDRL ANTIGEN, manufactured by Centers For Disease Control and Prevention. The device is a Class 2 Microbiology device with product code GMQ cleared through the Traditional 510(k) pathway after a 119-day FDA review.

K993633 · Centers For Disease Control and Prevention · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2000
Decision
119d
Days
Class 2
Risk

K993633 is an FDA 510(k) clearance for the SYNTHETIC VDRL ANTIGEN. Classified as Antigens, Nontreponemal, All (product code GMQ), Class II - Special Controls.

Submitted by Centers For Disease Control and Prevention (Atlanta, US). The FDA issued a Cleared decision on February 23, 2000 after a review of 119 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3820 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Centers For Disease Control and Prevention devices

FDA 510(k) Submission Details - K993633

510(k) Number K993633 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 27, 1999
Decision Date February 23, 2000
Days to Decision 119 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d slower than avg
Panel avg: 102d · This submission: 119d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GMQ Device Classification - Class 2, Special Controls

Product Code GMQ Antigens, Nontreponemal, All
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3820
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - GMQ Antigens, Nontreponemal, All

All 22
Devices cleared under the same product code (GMQ) and FDA review panel - the closest regulatory comparables to K993633.
ASI Evolution
K173376 · Arlington Scientific, Inc. (Asi) · Jun 2018
Gold Standard Diagnostics AIX1000 Rapid Plasma Reagin (RPR) Automated Test System
K150358 · Gold Standard Diagnostics · Nov 2015
THE DAYA SYPHILIS TEST/THE TRUST ANTIGEN TEST
K000687 · Beacon Biologicals, Inc. · Jun 2000
AVANTI POLAR LIPIDS VDRL ANTIGEN SLIDE TEST KIT WITH 10 X 0.5 ML AMPULES, AVANTI POLAR LIPIDS BULK BDRL ANTIGEN, AVANTI
K992124 · Avanti Polar Lipids, Inc. · Sep 1999
TRUST
K954994 · Guardian Scientific, Corp. · Oct 1996
RPR CARD TEST KIT
K955136 · Remel, L.P. · Jul 1996